Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen

Abstract Background Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen....

Full description

Bibliographic Details
Main Authors: Cecilia Ferreyra, Daniel O’Brien, Beatriz Alonso, Abdulbasset Al-Zomour, Nathan Ford
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Conflict and Health
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13031-018-0161-1
_version_ 1828837309641916416
author Cecilia Ferreyra
Daniel O’Brien
Beatriz Alonso
Abdulbasset Al-Zomour
Nathan Ford
author_facet Cecilia Ferreyra
Daniel O’Brien
Beatriz Alonso
Abdulbasset Al-Zomour
Nathan Ford
author_sort Cecilia Ferreyra
collection DOAJ
description Abstract Background Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. Case presentation In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. Conclusions This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings.
first_indexed 2024-12-12T18:39:15Z
format Article
id doaj.art-b4997b3e73f14736b873456f60eb2352
institution Directory Open Access Journal
issn 1752-1505
language English
last_indexed 2024-12-12T18:39:15Z
publishDate 2018-07-01
publisher BMC
record_format Article
series Conflict and Health
spelling doaj.art-b4997b3e73f14736b873456f60eb23522022-12-22T00:15:42ZengBMCConflict and Health1752-15052018-07-011211710.1186/s13031-018-0161-1Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and YemenCecilia Ferreyra0Daniel O’Brien1Beatriz Alonso2Abdulbasset Al-Zomour3Nathan Ford4Médecins sans Frontières SpainMédecins sans FrontièresMédecins sans Frontières SpainNational AIDS ProgramCentre for Infectious Disease Epidemiology and Research, University of Cape TownAbstract Background Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. Case presentation In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. Conclusions This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings.http://link.springer.com/article/10.1186/s13031-018-0161-1HIVConflictContingency planEmergency response
spellingShingle Cecilia Ferreyra
Daniel O’Brien
Beatriz Alonso
Abdulbasset Al-Zomour
Nathan Ford
Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
Conflict and Health
HIV
Conflict
Contingency plan
Emergency response
title Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_full Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_fullStr Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_full_unstemmed Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_short Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
title_sort provision and continuation of antiretroviral therapy during acute conflict the experience of msf in central african republic and yemen
topic HIV
Conflict
Contingency plan
Emergency response
url http://link.springer.com/article/10.1186/s13031-018-0161-1
work_keys_str_mv AT ceciliaferreyra provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT danielobrien provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT beatrizalonso provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT abdulbassetalzomour provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen
AT nathanford provisionandcontinuationofantiretroviraltherapyduringacuteconflicttheexperienceofmsfincentralafricanrepublicandyemen